Advanced Enzyme closed its buyback after purchasing 2,410,906 shares for ₹69.70 Crore. Closure took effect October 30, 2026, ahead of the scheduled period.
Advanced Enzyme Technologies bought back 54,455 equity shares via Emkay Global on October 29, 2026 at an average of ₹263.76. Cumulative buyback stands at 24,10,906 shares under the ongoing open-market programme.
Advanced Enzyme bought back 64,583 shares on 28-10-2026 at an average ₹262.49, totalling 23,56,451 shares to date. Purchases were made via Emkay Global on the open market.
Advanced Enzyme bought back 29,115 shares on October 27, 2026, worth about ₹0.75 Crore. Cumulative buyback stands at 22,91,868 shares under its open-market programme.
Advanced Enzyme Technologies bought back 40,000 shares on October 14, 2026, at an average price of ₹268.00 per share, totaling approximately ₹1.07 Crore.
Advanced Enzyme Technologies bought back 30,000 shares today at an average price of ₹274.96. This daily report confirms shares acquired under the company's buyback program.
Advanced Enzyme Technologies bought back 25,000 equity shares at an average price of ₹285.61 on September 30, 2026, as part of its ongoing buyback program.
Advanced Enzyme Technologies Ltd bought back 25,000 equity shares at an average price of ₹288.41 per share, totalling ₹0.72 Crore, under its ongoing buyback programme.
Advanced Enzyme Technologies Ltd bought back 50,000 equity shares on September 25, 2026. This transaction was executed at an average price of ₹295.80 per share.
Advanced Enzyme Technologies Ltd repurchased 1,136 equity shares on September 22, 2026, at an average price of ₹295.90. This daily filing is for compliance.
Advanced Enzyme Technologies bought back 55,665 shares on September 16, 2026, at an average price of ₹291.25 per share. Total cumulative buyback stands at 1,297,422 shares.
Advanced Enzyme Technologies bought back 53,607 shares on September 15, 2026, at an average price of ₹294.6372 per share, totaling approximately ₹1.58 Crore.
Advanced Enzyme Technologies bought 46,212 shares on September 09, 2026, at an average price of ₹299.5388 per share as part of its ongoing buyback programme.
Advanced Enzyme Technologies extinguished 8,25,028 equity shares (face value ₹2) bought back in August 2026. The certificate confirms compliance with SEBI Buy-Back Regulations.
Advanced Enzyme Technologies Ltd reported the buyback of 31,197 equity shares on September 07, 2026. The average acquisition price was ₹295.9121 per share.
Advanced Enzyme Technologies bought back 58,083 equity shares on September 02, 2026, at an average price of ₹295.3153 per share, totaling 9,41,885 cumulative shares.
Advanced Enzyme Technologies bought 58,774 shares at an average price of ₹296.05 on September 01, 2026. This daily update confirms the company's ongoing share buyback program.